Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122073877 | 12207387 | 7 | F | 20160127 | 20160720 | 20160324 | 20160803 | EXP | GB-MHRA-ADR 23392992 | GB-PFIZER INC-2016159615 | PFIZER | 30.00 | YR | F | Y | 0.00000 | 20160803 | OT | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122073877 | 12207387 | 1 | SS | CYCLOPHOSPHAMIDE. | CYCLOPHOSPHAMIDE | 1 | UNK | U | 0 | ||||||||||
| 122073877 | 12207387 | 2 | PS | EPIRUBICIN HCL | EPIRUBICIN HYDROCHLORIDE | 1 | UNK | U | 50778 | SOLUTION FOR INJECTION | |||||||||
| 122073877 | 12207387 | 3 | SS | EPIRUBICIN HCL | EPIRUBICIN HYDROCHLORIDE | 1 | UNK | U | 50778 | SOLUTION FOR INJECTION | |||||||||
| 122073877 | 12207387 | 4 | SS | FLUOROURACIL. | FLUOROURACIL | 1 | UNK | U | 0 | ||||||||||
| 122073877 | 12207387 | 5 | SS | DEXAMETHASONE SODIUM PHOSPHATE. | DEXAMETHASONE SODIUM PHOSPHATE | 1 | UNK | U | 0 | ||||||||||
| 122073877 | 12207387 | 6 | SS | DEXAMETHASONE SODIUM PHOSPHATE. | DEXAMETHASONE SODIUM PHOSPHATE | 1 | UNK | U | 0 | ||||||||||
| 122073877 | 12207387 | 7 | SS | NEULASTA | PEGFILGRASTIM | 1 | UNK, CYCLE 2 DAY 9 | U | 0 | ||||||||||
| 122073877 | 12207387 | 8 | SS | ZOMETA | ZOLEDRONIC ACID | 1 | UNK | U | 0 | ||||||||||
| 122073877 | 12207387 | 9 | SS | LEVOMEPROMAZINE | LEVOMEPROMAZINE | 1 | UNK | U | 0 | ||||||||||
| 122073877 | 12207387 | 10 | SS | LEVOMEPROMAZINE | LEVOMEPROMAZINE | 1 | UNK | U | 0 | ||||||||||
| 122073877 | 12207387 | 11 | SS | METOCLOPRAMIDE. | METOCLOPRAMIDE | 1 | UNK | U | 0 | ||||||||||
| 122073877 | 12207387 | 12 | SS | ONDANSETRON HYDROCHLORIDE. | ONDANSETRON HYDROCHLORIDE | 1 | UNK | U | 0 | ||||||||||
| 122073877 | 12207387 | 13 | SS | ONDANSETRON HYDROCHLORIDE. | ONDANSETRON HYDROCHLORIDE | 1 | UNK | U | 0 | ||||||||||
| 122073877 | 12207387 | 14 | SS | TAXOTERE | DOCETAXEL | 1 | UNK | U | 0 | ||||||||||
| 122073877 | 12207387 | 15 | SS | APREPITANT. | APREPITANT | 1 | UNK | U | 0 | ||||||||||
| 122073877 | 12207387 | 16 | SS | CALCICHEW D3 | CALCIUMCHOLECALCIFEROL | 1 | UNK | U | 0 |
Indications of drugs used
| no results found |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 122073877 | 12207387 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 122073877 | 12207387 | Alopecia | |
| 122073877 | 12207387 | Back pain | |
| 122073877 | 12207387 | Constipation | |
| 122073877 | 12207387 | Dysgeusia | |
| 122073877 | 12207387 | Fatigue | |
| 122073877 | 12207387 | Neuropathy peripheral | |
| 122073877 | 12207387 | Paraesthesia oral | |
| 122073877 | 12207387 | Phlebitis | |
| 122073877 | 12207387 | Skin discolouration | |
| 122073877 | 12207387 | Sunburn |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |